OverviewSuggest Edit

    Cerapedics is an orthobiologics company that is engaged in the development and commercialization of synthetic small peptide (P-15) technology platform. Its i-FACTOR Enhanced Bone Graft is a biologic bone graft that incorporates a small peptide as an attachment factor bound to an organic bone mineral (ABM). This mechanism is designed to stimulate the natural bone healing process and support more predictable bone formation.

    Latest Updates

    Employees (est.) (Mar 2020)64

    Key People/Management at Cerapedics

    Jeffrey G. Marx

    Jeffrey G. Marx

    President & COO
    Andrew W. Barnes

    Andrew W. Barnes

    VP of U.S. Sales
    Jerome Connor

    Jerome Connor

    VP of Research and Development
    Roger N. White

    Roger N. White

    VP of Clinical and Regulatory Affairs
    Andy Woods

    Andy Woods

    Senior Director of OUS Commercial Development
    Scott Johnson

    Scott Johnson

    Senior Director of Clinical Education and Marketing
    Show more

    Cerapedics Financials and Metrics

    Summary Metrics

    Founding Date

    Show all financial metrics

    Cerapedics Online and Social Media Presence

    Embed Graph

    Cerapedics Frequently Asked Questions

    • When was Cerapedics founded?

      Cerapedics was founded in 2001.

    • Who are Cerapedics key executives?

      Cerapedics's key executives are Jeffrey G. Marx, Andrew W. Barnes and Jerome Connor.

    • How many employees does Cerapedics have?

      Cerapedics has 64 employees.

    • Who are Cerapedics competitors?

      Competitors of Cerapedics include Histogen, Cocoon Biotech and Chemotargets.